200P-500HI fetal bovine serum, prim E,500 ML, lot #915045

Ended Awarded

Contract number
HHSN266NYU39631
Awardee
Awarding agency
Obligated
$13,464

Award facts

Contract value
  • $13,464.00 Current, with exercised options
  • $0.00 Potential, with all options
Completion date
  • Current, with exercised options
  • Not on record Potential, with all options
Funding agency
Office of the Director National Institutes of Health, Department of Health and Human Services
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
0 offers Simplified Acquisition
Pricing
Other

Award details come from SAM.gov/FPDS.

Quick answers

Who was awarded contract HHSN266NYU39631?

HHSN266NYU39631 was awarded to Biosource International Incorporated by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 1, 2005.

How much is contract HHSN266NYU39631 worth?

The government has obligated $13,464 on HHSN266NYU39631.

Which agency awarded contract HHSN266NYU39631?

National Institute of Allergy and Infectious Diseases (National Institutes of Health) awarded HHSN266NYU39631, with funding from Office of the Director (National Institutes of Health).

Is contract HHSN266NYU39631 an order under another contract?

Yes. HHSN266NYU39631 is a BPA call under HHSN263200500062483B, a blanket purchase agreement.

Was contract HHSN266NYU39631 competed?

The government received 0 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award